Our Partners

As part of our mission to improve women’s health in midlife and menopause, Gennevis working with medical professionals, scientists, and other organizations to promote the very best in women’s health care. Together with our partners, we’re connecting women with experts, studies, resources, and support, bringing menopause into mainstream conversation, and working to increase every woman’s access to quality care for the second chapter of her life.

MiraKind was founded in 2013 as a way to help women understand and modify their risk of certain kinds of cancer. The genetic marker known as the KRAS-variant, discovered by MiraKind’s founder, Dr. Joanne Weidhaas, is a strong predictor of multiple cancers. The KRAS-variant has been shown to be triggered by a drop in estrogen – making MiraKind’s research particularly important for women in menopause. We’re partnering with MiraKind to help spread the word for women to get tested for the KRAS-variant, so they can make the best decisions for their long-term health.